Japanese Encephalitis Vaccine: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 26: | Line 26: | ||
[[Category:Japanese encephalitis]] | [[Category:Japanese encephalitis]] | ||
{{stb}} | {{stb}} | ||
__NOINDEX__ | |||
Latest revision as of 07:46, 4 February 2025
Japanese Encephalitis Vaccine is a vaccine used to protect against Japanese encephalitis (JE), a disease caused by the Japanese encephalitis virus (JEV). This virus is a type of Flavivirus that is transmitted by mosquitoes. The disease is most prevalent in rural and suburban areas of Southeast Asia, the Pacific Islands, and the Far East. JE is a serious condition that can cause encephalitis (inflammation of the brain), leading to symptoms ranging from mild fever to severe brain damage or even death. Vaccination is the most effective way to prevent Japanese encephalitis.
Types of Japanese Encephalitis Vaccines[edit]
There are several types of JE vaccines available, including inactivated vaccines and live attenuated vaccines. The most commonly used vaccines are:
- Inactivated Vero cell culture-derived vaccines (e.g., IXIARO, JESPECT): These vaccines are produced by growing the JEV in Vero cells (a type of cell line), inactivating the virus, and then purifying it. They are considered safe and effective for individuals aged 2 months and older.
- Live attenuated vaccines (e.g., SA 14-14-2): This vaccine is made by weakening the virus so that it cannot cause disease. It is widely used in endemic countries and is approved for use in individuals aged 1 year and older.
Vaccination Schedule[edit]
The vaccination schedule for Japanese encephalitis vaccine varies depending on the specific vaccine used. Generally, the inactivated JE vaccine is administered in two doses, 28 days apart. A booster dose may be recommended for ongoing protection in people who remain at risk. The live attenuated vaccine is usually given as a single dose.
Effectiveness and Duration of Protection[edit]
The Japanese encephalitis vaccine is highly effective in preventing JE. The protection rate is approximately 90% or higher for both types of vaccines. The duration of protection varies; the inactivated vaccine provides immunity for at least 1 year and possibly up to 2 years after the primary immunization series, with longer protection after a booster dose. The live attenuated vaccine has been shown to provide immunity for at least 5 years.
Side Effects[edit]
Common side effects of the Japanese encephalitis vaccine are mild and may include pain and redness at the injection site, headache, muscle pain, and fever. Serious side effects are rare but can include allergic reactions.
Travel and Vaccination[edit]
The Centers for Disease Control and Prevention (CDC) recommends JE vaccination for travelers who plan to spend a month or more in endemic areas during the JE virus transmission season, especially if travel will include rural or outdoor activities. Vaccination is also recommended for shorter trips if the traveler's activities will increase their risk of JE virus exposure.
Conclusion[edit]
The Japanese encephalitis vaccine is a critical tool in preventing JE, a potentially fatal disease. With high effectiveness and a good safety profile, vaccination is recommended for those at risk due to travel or residence in endemic areas. As with any vaccine, individuals should consult with healthcare providers to determine their specific vaccination needs.
| This article is a stub. You can help WikiMD by registering to expand it. |